Concepedia

Publication | Closed Access

Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)

69

Citations

19

References

2007

Year

References

YearCitations

Page 1